We developed an eribulin-resistant leiomyosarcoma cell line to investigate the mechanism underlying resistance and found that TUBB3 overexpression induced chemoresistance to eribulin and knockdown of TUBB3 expression by siRNA led to chemosensitization to eribulin in the resistant cell line. Here, TUBB3 is linked to leiomyosarcoma.